GlassScriptPhysician profile
Kenneth John Herwig
NPI 1205932415
$2,569.11
in general payments reported to CMS, 2019-2025
16 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $840 · 2020: $532 · 2021: $406 · 2022: $263 · 2023: $134 · 2024: $274 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $528.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $586.84 | 2019-2022 | |
| Amgen INC. | $389.36 | 2019-2021 | |
| Boston Scientific Corporation | $268.41 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $242.61 | 2020-2023 | |
| Janssen Pharmaceuticals, INC | $149.76 | 2019 | |
| Scpharmaceuticals INC. | $149.26 | 2024 | |
| Abbvie INC. | $135.64 | 2022 | |
| Medtronic Vascular, INC. | $130.26 | 2019 | |
| Corcept Therapeutics | $125.00 | 2024 | Korlym |
| Agepha Pharma Fz LLC | $120.00 | 2025 | Lodoco |
| Allergan, INC. | $115.82 | 2020 | |
| Novartis Pharmaceuticals Corporation | $58.18 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $37.96 | 2019 | |
| Optinose US, INC. | $24.06 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $19.97 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alfasigma USA, INC. | $15.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Herwig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.